Form 10-Q SKYSTAR BIO-PHARMACEUTIC For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Skystar Bio-Pharma (SKBI) Reports Q2 EPS of $0.37
August 15, 2014 7:37 AM EDTSkystar Bio-Pharma (NASDAQ: SKBI) reported Q2 EPS of $0.37, versus $0.49 reported last year. Revenue for the quarter came in at $14.2 million, versus $11.3 million reported last year.
For earnings history and earnings-related data on Skystar Bio-Pharma (SKBI) click here.
... More